11-C-substituted ketolides

   
   

There are described 11-C-substituted derivatives of erythromycin and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described is a method for treating bacterial infections by administering to an animal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for the preparation of such compounds.

Будут описанные производные 11-C-substituted эритромицина и фармацевтически приемлемо составов состоя из терапевтически эффективного количества смеси вымысла in combination with фармацевтически приемлемо несущая. Также описан метод для обрабатывать бактериальные инфекции путем administering к животному фармацевтический состав содержа терапевтическ-3ffektivnoe количество смеси вымысла, и процессы для подготовки таких смешивают.

 
Web www.patentalert.com

< Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor

< Transmissive or reflective liquid crystal display and novel process for its manufacture

> Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same

> Controlled release of bioactive substances

~ 00116